Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience.
Detti B, Franceschini D, Saieva C, Di Brina L, Baki M, Meattini I, Di Cataldo V, Pasquetti EM, Furfaro I, Mancuso A, Simontacchi G, Livi L. Detti B, et al. Among authors: franceschini d. Cancer Invest. 2015;33(7):329. doi: 10.3109/07357907.2015.1060063. Epub 2015 Jul 2. Cancer Invest. 2015. PMID: 26135542 No abstract available.
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.
Livi L, Meattini I, Saieva C, Franzese C, Di Cataldo V, Greto D, Franceschini D, Scotti V, Bonomo P, Nori J, Sanchez L, Vezzosi V, Bianchi S, Cataliotti L, Biti G. Livi L, et al. Among authors: franceschini d. Cancer. 2012 Jul 1;118(13):3236-43. doi: 10.1002/cncr.26647. Epub 2011 Oct 25. Cancer. 2012. PMID: 22028054 Free article.
Treatment of invasive male breast cancer: a 40-year single-institution experience.
Meattini I, Livi L, Franceschini D, Saieva C, Scotti V, Casella D, Criscenti V, Zanna I, Meacci F, Gerlain E, Agresti B, Mangoni M, Paiar F, Simontacchi G, Greto D, Nori J, Bianchi S, Cataliotti L, Biti G. Meattini I, et al. Among authors: franceschini d. Radiol Med. 2013 Apr;118(3):476-86. doi: 10.1007/s11547-012-0867-x. Epub 2012 Aug 8. Radiol Med. 2013. PMID: 22872459
Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment.
Detti B, Scoccianti S, Franceschini D, Cipressi S, Cassani S, Villari D, Gacci M, Pupi A, Vaggelli L, Saieva C, Pertici M, Livi L, Ceroti M, Nicita G, Carini M, Biti G. Detti B, et al. Among authors: franceschini d. J Cancer Res Clin Oncol. 2013 Mar;139(3):521-8. doi: 10.1007/s00432-012-1354-4. Epub 2012 Nov 27. J Cancer Res Clin Oncol. 2013. PMID: 23183655
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience.
Greto D, Paiar F, Saieva C, Galardi A, Mangoni M, Livi L, Agresti B, Franceschini D, Bonomo P, Scotti V, Detti B, Tonelli F, Valeri A, Messerini L, Biti G. Greto D, et al. Among authors: franceschini d. Radiol Med. 2013 Jun;118(4):570-82. doi: 10.1007/s11547-012-0909-4. Epub 2013 Jan 28. Radiol Med. 2013. PMID: 23358814
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L, Meattini I, Franceschini D, Saieva C, Meacci F, Marrazzo L, Gerlain E, Desideri I, Scotti V, Nori J, Sanchez LJ, Orzalesi L, Bonomo P, Greto D, Bianchi S, Biti G. Livi L, et al. Among authors: franceschini d. Radiother Oncol. 2013 Aug;108(2):273-8. doi: 10.1016/j.radonc.2013.02.009. Epub 2013 Mar 13. Radiother Oncol. 2013. PMID: 23490271
Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
Meattini I, Livi L, Franceschini D, Saieva C, Meacci F, Marrazzo L, Bendinelli B, Scotti V, De Luca Cardillo C, Nori J, Sanchez L, Orzalesi L, Bonomo P, Greto D, Bucciolini M, Bianchi S, Biti G. Meattini I, et al. Among authors: franceschini d. Eur J Surg Oncol. 2013 Jun;39(6):613-8. doi: 10.1016/j.ejso.2013.03.002. Epub 2013 Mar 20. Eur J Surg Oncol. 2013. PMID: 23523088
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
Meattini I, Livi L, Saieva C, Franceschini D, Scotti V, Mangoni M, Loi M, Di Brina L, Zei G, Bonomo P, Greto D, Gelain E, Nori J, Sanchez LJ, Orzalesi L, Bianchi S, Biti G. Meattini I, et al. Among authors: franceschini d. Clin Breast Cancer. 2013 Aug;13(4):247-53. doi: 10.1016/j.clbc.2013.02.005. Epub 2013 May 15. Clin Breast Cancer. 2013. PMID: 23684167
236 results